Condition
Biliary Cirrhosis, Primary
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02932449CompletedPrimary
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02360852Phase 2TerminatedPrimary
IBAT Inhibitor A4250 for Cholestatic Pruritus
NCT00242125UnknownPrimary
Family Studies in Primary Biliary Cirrhosis (PBC)
NCT00145964Unknown
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Showing all 4 trials